Skeletal muscle relaxants Pharmacokinetics Indications Chlorzoxazone synthesis Medicine interactions Side effects Uses Category Toxicity grading Acute toxicity Flammability and hazard properties Storage characteristics Extinguishing agent
ChemicalBook > CAS DataBase List > Chlorzoxazone

Chlorzoxazone

Skeletal muscle relaxants Pharmacokinetics Indications Chlorzoxazone synthesis Medicine interactions Side effects Uses Category Toxicity grading Acute toxicity Flammability and hazard properties Storage characteristics Extinguishing agent
Chlorzoxazone Structure
Chlorzoxazone
  • CAS No.95-25-0
  • Chemical Name:Chlorzoxazone
  • CBNumber:CB0392987
  • Molecular Formula:C7H4ClNO2
  • Formula Weight:169.57
  • MOL File:95-25-0.mol
Chlorzoxazone Property
  • Melting point 191-192 °C (lit.)
  • Density 1.3771 (rough estimate)
  • refractive index 1.5557 (estimate)
  • storage temp. room temp
  • solubility DMSO: soluble50mg/mL, clear
  • pka pKa 8.3 (Uncertain)
  • form Powder
  • color white to off-white
  • Water Solubility 0.1 g/100 mL
  • Merck 14,2194
  • LogP 1.816 (est)
  • CAS DataBase Reference 95-25-0(CAS DataBase Reference)
  • EWG's Food Scores 1
  • FDA UNII H0DE420U8G
  • NCI Drug Dictionary chlorzoxazone
  • ATC code M03BB03
  • NIST Chemistry Reference Chlorzoxazone(95-25-0)
  • EPA Substance Registry System Chlorzoxazone (95-25-0)
  • UNSPSC Code 41116107
  • NACRES NA.77
Safety
  • Hazard Codes  :Xn,T,Xi
  • Risk Statements  :22-36/37/38-20/21/22
  • Safety Statements  :26-36-24/25-37/39
  • WGK Germany  :3
  • RTECS  :DM5250000
  • Hazard Note  :Toxic/Irritant
  • TSCA  :Yes
  • HazardClass  :IRRITANT
  • HS Code  :29349990
  • Toxicity :LD50 in mice (mg/kg): 3650 orally, 380 i.p. (suspensions); 440 orally, 183 i.p. (solns of Na salt) (Hofrichter)
  • NFPA 704:
    1
    2 0
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal wordWarning
  • Hazard statements H302-H315-H319-H335
  • Precautionary statements P261-P264-P270-P301+P312-P302+P352-P305+P351+P338
Chlorzoxazone Price More Price(4)
  • Brand: Sigma-Aldrich(India)
  • Product number: C4397
  • Product name : Chlorzoxazone
  • Purity: 
  • Packaging: 25G
  • Price: ₹8898.15
  • Updated: 2022/06/14
  • Buy: Buy
  • Brand: Sigma-Aldrich(India)
  • Product number: PHR1919
  • Product name : Chlorzoxazone
  • Purity: Pharmaceutical Secondary Standard; Certified Reference Material
  • Packaging: 500MG
  • Price: ₹19863.88
  • Updated: 2022/06/14
  • Buy: Buy
  • Brand: Sigma-Aldrich(India)
  • Product number: C4397
  • Product name : Chlorzoxazone
  • Purity: 
  • Packaging: 100G
  • Price: ₹24377.9
  • Updated: 2022/06/14
  • Buy: Buy
  • Brand: TCI Chemicals (India)
  • Product number: C2237
  • Product name : Chlorzoxazone
  • Purity: min. 98.0 %
  • Packaging: 25G
  • Price: ₹2400
  • Updated: 2022/05/26
  • Buy: Buy

Chlorzoxazone Chemical Properties,Usage,Production

  • Skeletal muscle relaxants Chlorzoxazone is an orally active central skeletal muscle relaxant with its chemical structure being completely different with all the other muscle relaxants. It, mainly through acting on the central cerebral cortex and the spinal cord, inhibits the multi-synaptic reflection related to muscle spasms and produces muscle relaxation, further relieves the spasm caused pain and increase the flexibility of the muscles involved. Acetaminophen belongs to non-steroidal anti-inflammatory drugs and may mainly exert the analgesic and antipyretic effects through the inhibition of prostaglandin synthesis. Muscle relaxation studies through mouse traction test have demonstrated that the compound Chlorzoxazone showed a dose-dependent muscle relaxant effect with excellent protective effect on the strychnine-induced seizures in mice. The existence of paracetamol in the compound chlorzoxazone tablets can further enhance the effect of chlorzoxazone. Hot plate analgesic tests have showed the compound chlorzoxazone has a significant analgesic effect in a dose-dependent manner. It also has antagonism effect on the painful writhing of mice caused by antimony potassium tartrate in a good dose-response relationship. Test results have showed that acetaminophen and chlorzoxazone analgesic synergy.
    This information is edited by Xiongfeng Dai from Chemicalbook.
  • Pharmacokinetics This product can be completely absorbed by the digestive tract with the plasma concentration reaching peak at 1.5-2 hours. It is distributed in muscle, kidney, liver, brain and fat. After 6 hours, the drug concentration decreases significantly. Almost all of the goods can subject to in vivo catabolism with the elimination half-life being about 1 hour.
    This information is edited by Xiongfeng Dai from Chemicalbook.
  • Indications Chlorzoxazone is suitable for the treatment of various kinds of acute and chronic soft tissue (muscles, ligaments and fascia) sprain, contusion, muscle pain after exercise, pain caused by muscle strain and the muscle spasms caused by the central nervous system lesions as well as chronic fasciitis.
  • Chlorzoxazone synthesis Take 2, 5-dichloro-nitrobenzene as raw material; go through hydrolysis, reduction reaction to give 2-amino-4-chloro-phenol, followed by cyclization reaction in hydrochloric acid to obtain the finished product of Chlorzoxazone with the total yield being 84%.

  • Medicine interactions When this product is used in combination with central inhibitory drugs such as phenothiazines and barbituric acid derivative and monoamine oxidase inhibition drugs, we should reduce the usage amount of this product.
  • Side effects There may be occasionally mild drowsiness, dizziness, nausea, heart palpitations, weakness, abdominal pain and other reactions. This drug should be discontinued in case of allergic reactions. These adverse reactions are generally mild and may go away automatically or alleviated after stopping using this drug.
  • Uses It can be used as pharmaceutical intermediates.
    It can be used as central muscle relaxants, for being applied to a variety of soft tissue pain caused by chronic sprain, contusion and muscle strain as well as muscle spasms and pain caused by the central nervous system and so on.
  • Category Toxic substances.
  • Toxicity grading Highly toxic.
  • Acute toxicity Oral-rat LD50: 763 mg/kg; Oral-Mouse LD50: 440 mg/kg.
  • Flammability and hazard properties Thermal decomposition can release nitrogen oxides and chlorides smoke.
  • Storage characteristics Treasury: ventilated, low temperature and dry; store it separately from food raw materials.
  • Extinguishing agent Water, carbon dioxide, foam, powder.
  • Description Chlorzoxazone is a muscle relaxant. It acts by blocking nerve impulses or pain sensations that are sent to brain. Typically, it is used together with rest and physical therapy to treat skeletal muscle conditions such as pain or injury. Chlorzoxazone, 5-chloro-2-benzoxazolione, is synthesized by a heterocyclization reaction of 2-amino-4-chlorophenol with phosgene. Skeletal muscle relaxants have conventionally been classified into one group; however, they are actually a heterogeneous group of medications commonly used to treat two different types of underlying conditions – spasticity from upper motor neuron syndromes and muscular pain or spasms from peripheral musculoskeletal conditions. Medications classified as skeletal muscle relaxants are baclofen, carisoprodol, chlorzoxazone, cyclobenzaprine, dantrolene, metaxalone, methocarbamol, orphenadrine, and tizanidine. These drugs may impair mental and/or physical abilities required for driving vehicles. As a class, skeletal muscle relaxants have central nervous system (CNS)-related side effects: drowsiness, dizziness, decreased alertness, blurred vision, and ataxia. Their use has been associated with a twofold increase in the risk for motor vehicle crashes. Muscle relaxants are included in the ‘Beers List’ of potentially inappropriate medications in older adults. Most muscle relaxants are poorly tolerated by elderly patients because they cause anticholinergic adverse effects, sedation, and weakness. Although extremely uncommon, this compound may yield to idiosyncratic and unpredictable type of liver toxicity. The concomitant use of alcohol or other CNS depressants may have an additive effect. Individuals on chlorzoxazone containing drugs should be monitored for abnormal liver enzymes (e.g., aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase, bilirubin, etc.).
  • Description Chlorzoxazone is a centrally acting muscle relaxant and activator of small and intermediate conductance calcium-activated potassium channels (EC50s = 87 and 98 μM for KCa2.2 and KCa3.1, respectively). In vivo, chlorzoxazone (10 mg/kg) decreases alcohol but not water intake in a dose-dependent manner and reduces the propensity for rapid initial alcohol intake in rats with intermittent, but not continuous, access to alcohol. Formulations containing chlorzoxazone have been used in the treatment of pain and stiffness caused by muscle spasm. This product is also available as an analytical reference standard .
  • Description Chlorzoxazone (Item No. 25826) is an analytical reference standard categorized as a skeletal muscle relaxant. This product is intended for analytical forensic applications. This product is also available as a general research tool .
  • Chemical Properties White to Off-White Solid
  • Originator Paraflex ,McNeil, US ,1958
  • Uses For the relief of discomfort associated with acute painful musculoskeletal conditions.
  • Uses Muscle relaxant (skeletal)
  • Uses Chlorzoxazone is a benzoxazolone derivative that causes skeletal muscle relaxation and blocks spasticity in clinical studies. Chlorzoxazone enhances small and intermediate conductance calcium-activated potassium channels (EC50s = 87 and 98 μM for KCa2.2 and KCa3.1, respectively). The cytochrome P450 isoform CYP2E1 converts chlorzoxazone to 6-hydroxy chlorzoxazone . The urinary excretion of this 6-hydroxy metabolite is often used as a probe of CYP2E1 activity in studies of hepatotoxicity.
  • Definition ChEBI: A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful mus le spasm.
  • Manufacturing Process A solution of 16.9 g (0.1 mol) of 2-amino-5-chlorobenzoxazole in 200 ml of 1 N HCl is refluxed until precipitation is complete. The resulting solid is collected
    by filtration, dissolved in 200 ml of 1 N NaOH and the solution extracted with 50 ml of ether. Acidification of the alkaline solution gives a precipitate which is purified by crystallization from acetone to give 2-hydroxy-5-chlorobenzoxazole melting at 191° to 191.5°C.
  • brand name Paraflex (Ortho-McNeil).
  • Therapeutic Function Muscle relaxant
  • General Description Chlorzoxazone is a centrally active muscle relaxant used to treat painful muscle spasms linked to musculoskeletal disorders, such as fibrositis, bursitis, myositis, spondylitis, etc.
    Pharmaceutical secondary standard for application in quality control. Provides pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
  • Biochem/physiol Actions Chlorzoxazone is a skeletal muscle relaxant.
  • Synthesis Chlorzoxazone, 5-chloro-2-benzoxazolione (15.3.15), is synthesized by a hetercyclization reaction of 2-amino-4-chlorphenol with phosgene.

    Synthesis_95-25-0

  • Environmental Fate Chlorzoxazone ismetabolized by the CYP1A2 and CYP2E1 microsomal enzymes to a toxic metabolite 6-hydroxychlorzoxazone.
  • Toxicity evaluation Chlorzoxazone is a white to off-white solid. It is soluble in organic solvents such as ethanol, methanol, and dimethyl sulfoxide (DMSO).
Chlorzoxazone Preparation Products And Raw materials
Raw materials
Preparation Products
Global(405)Suppliers
  • Supplier:
    Henan Tianfu Chemical Co.,Ltd.
  • Tel:+86-0371-55170693<br/>+86-19937530512
  • Email:info@tianfuchem.com
  • Country:China
  • ProdList:21628
  • Advantage:55
  • Supplier:
    Zjartschem
  • Tel:+86-571 87238903
  • Email:jocelynpan@zjarts.com
  • Country:CHINA
  • ProdList:988
  • Advantage:58
  • Supplier:
    career henan chemical co
  • Tel:+86-0371-86658258<br/>+8613203830695
  • Email:sales@coreychem.com
  • Country:China
  • ProdList:29859
  • Advantage:58
  • Supplier:
    Xiamen AmoyChem Co., Ltd
  • Tel:+86-86-5926051114<br/>+8615060885618
  • Email:sales@amoychem.com
  • Country:China
  • ProdList:6383
  • Advantage:58
  • Supplier:
    TargetMol Chemicals Inc.
  • Tel:+1-781-999-5354<br/>+1-00000000000
  • Email:marketing@targetmol.com
  • Country:United States
  • ProdList:32159
  • Advantage:58

Related articles

Chlorzoxazone Spectrum
95-25-0, ChlorzoxazoneRelated Search:
  • Pharmaceuticals
  • Intermediates & Fine Chemicals
  • Oxazole&Isoxazole
  • PARAFON
  • 抑制剂
  • 药靶配体
  • 合成有机化合物配体
  • 有机中间体
  • 生物化工
  • 化学试剂
  • 日用化学品
  • 1 ADME产品-体外代谢标准品
  • 原料药
  • 化工
  • 医药、农药及染料中间体
  • 化工原料
  • 中药对照品
  • 体外研究产品-体外代谢标准品
  • 医用原料
  • 原料
  • 抗炎镇痛药物
  • 原料药
  • 对照品
  • 化合物
  • 缓解疼痛
  • Palladium Catalysis 钯催化剂
  • 神经系统用药
  • 小分子抑制剂
  • 其他科研原料药
  • 医药原料
  • 维生素与氨基酸
  • 医药中间体
  • 中间体/精细化工品
  • BioChemical
  • Cell Signaling and Neuroscience
  • Cell Biology
  • Monovalent Ion Channels
  • Ion Channels
  • Voltage-gated Ion Channels
  • Potassium Channel Modulators
  • 氯唑沙宗,10 MM DMSO 溶液
  • 氯唑沙宗检测标准品
  • 氯唑沙宗/AR
  • 氯唑沙宗-13C,15N,D2
  • 5-氯苯并[D]噁唑-2(3H)-酮
  • 氯并恶唑酮
  • 氯唑沙宗(对照品)
  • 5-CHLORO-2-BENZOXAZOLINOONE 氯唑沙宗
  • CHLORZOXAZONE 氯唑沙宗(CYP2E1)
  • 5-氯苯并[D]恶唑-2(3H)-酮
  • 99.0%氯唑沙宗
  • CHLORZOXAZONE氯唑沙宗
  • 氯唑沙宗(CYP2E1)
  • 氯唑沙宗CHLORZOXAZONE
  • 氯唑沙宗 USP标准品
  • 氯唑沙宗95-25-0
  • 氯羟苯唑
  • 5-氯-2-苯并F唑酮